Health News
Date: Apr-03-2013
SMi Group are proud to announce that Polytherics, a UK Biotech company and Viventia, a Canadian biopharmaceutical company, will be sponsoring this years 2nd annual ADC Summit taking place on 20 - 21 May, London. Polytherics partners include Spirogen, who have recently announced research collaboration with Ablynx. The new group effort will evaluate a novel anti-cancer drug conjugate combining Spirogen's cytotoxic drugs, pyrrolobenzodiazepines (PBD), and associated linker technology, with Nanobodies generated using Ablynx's technology platform...
Date: Apr-03-2013
SMi Group is pleased to announce Vitalograph and Aerocrine as sponsors of the 9th instalment in the Asthma series, taking place on 15th and 16th April, London. "2013 is an exciting year for Vitalograph as we celebrate our 50th anniversary. We are particularly looking forward to the forthcoming SMI Asthma & COPD Conference where we will showcase our latest products and services including the new Compact workstation." Jonathan Pritchard, Business Development Manager, Clinical Trials, Vitalograph Ltd...
Date: Apr-03-2013
A Free Virtual Virology & Microbiology Conference at Targetmeeting.com featuring 60 live presentations (12 sessions) from academic and industry experts around the world. Computer and internet connection are required. Do not need any special equipment or software. All the attendees just connect to the online conference's server to participate in real time with their distinguished counterparts from across the globe. They can participate from their home or office depending on their convenience, which will save them the trouble of traveling and in utilizing their time optimally...
Date: Apr-03-2013
New research that links the causes of age-related macular degeneration (AMD) with clogged arteries suggests anti-cholesterol drugs may halt the eye disease, the leading cause of blindess among older people in the US. In the 2 April issue of Cell Metabolism, senior investigator Rajendra S. Apte, of the Washington University School of Medicine in St. Louis in the US, and colleagues, report how AMD and atherosclerosis share a common underlying problem: an inability to remove remove a buildup of fat and cholesterol. For their study, Apte, a Paul A...
Date: Apr-03-2013
Computer modeling may resolve conflicting results and offer hints for new drug-design strategies. Clumps of proteins that accumulate in brain cells are a hallmark of neurological diseases such as dementia, Parkinson's disease and Alzheimer's disease. Over the past several years, there has been much controversy over the structure of one of those proteins, known as alpha synuclein. MIT computational scientists have now modeled the structure of that protein, most commonly associated with Parkinson's, and found that it can take on either of two proposed states -- floppy or rigid...
Date: Apr-03-2013
Pencil beam scanning boosts accuracy, further minimizes radiation delivered to healthy tissue One of the most precise tools in the fight against cancer is now available to patients in the Midwest. The CDH Proton Center, A ProCure Center announced the installation of pencil beam scanning, which delivers a more precise dose of proton therapy to further minimize exposure of healthy tissue to radiation and allow radiation oncologists to better treat more complex tumors...
Date: Apr-03-2013
Pee in a cup and you might get a clue as to how much longer you will live. A new report published online today in the National Kidney Foundation's American Journal of Kidney Diseases shows a strong correlation between levels of protein in the urine, or proteinuria, and mortality. "Our report shows that both men and women with higher levels of proteinuria had substantially reduced life expectancy in comparison to people with relatively low levels of proteinuria," said the report's lead author, Dr. Tanvir Chowdhury Turin�of the University of Calgary...
Date: Apr-03-2013
Patients undergoing angioplasty or other heart-related medical procedures could benefit from a new technology being developed with funding from the National Science Foundation (NSF). Optical imaging technology from Wasatch Photonics Inc. creates images of coronary artery walls in vivo to show where lesions and plaques have formed. Physicians can use the images to determine the best course of action, including where a stent might be placed. William J...
Date: Apr-03-2013
Filing Based on Phase 3 Data in Treatment-Naïve and Treatment-Experienced Patients with Compensated Liver Disease Janssen Research & Development, LLC (Janssen) today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for simeprevir (TMC435), an investigational NS3/4A protease inhibitor, administered as a 150 mg capsule once daily with pegylated interferon and ribavirin for the treatment of genotype 1 chronic hepatitis C in adult patients...
Date: Apr-03-2013
Results Differ from Previous Research Showing Surgery Was Not a Viable Option Patients with primary breast cancer that has spread to the lungs may live longer if the lung metastases are surgically removed, according to a study published in the April 2013 issue of The Annals of Thoracic Surgery...